JPWO2020117618A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020117618A5
JPWO2020117618A5 JP2021531950A JP2021531950A JPWO2020117618A5 JP WO2020117618 A5 JPWO2020117618 A5 JP WO2020117618A5 JP 2021531950 A JP2021531950 A JP 2021531950A JP 2021531950 A JP2021531950 A JP 2021531950A JP WO2020117618 A5 JPWO2020117618 A5 JP WO2020117618A5
Authority
JP
Japan
Prior art keywords
present
amount
booster vaccine
optionally
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021531950A
Other languages
English (en)
Japanese (ja)
Other versions
JP7605739B2 (ja
JP2022511511A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063840 external-priority patent/WO2020117618A1/en
Publication of JP2022511511A publication Critical patent/JP2022511511A/ja
Publication of JPWO2020117618A5 publication Critical patent/JPWO2020117618A5/ja
Priority to JP2024126656A priority Critical patent/JP2024156862A/ja
Application granted granted Critical
Publication of JP7605739B2 publication Critical patent/JP7605739B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021531950A 2018-12-05 2019-11-29 百日咳ブースターワクチン Active JP7605739B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024126656A JP2024156862A (ja) 2018-12-05 2024-08-02 百日咳ブースターワクチン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18306621.6 2018-12-05
EP18306621 2018-12-05
PCT/US2019/063840 WO2020117618A1 (en) 2018-12-05 2019-11-29 Pertussis booster vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024126656A Division JP2024156862A (ja) 2018-12-05 2024-08-02 百日咳ブースターワクチン

Publications (3)

Publication Number Publication Date
JP2022511511A JP2022511511A (ja) 2022-01-31
JPWO2020117618A5 true JPWO2020117618A5 (enExample) 2022-11-09
JP7605739B2 JP7605739B2 (ja) 2024-12-24

Family

ID=65628487

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021531950A Active JP7605739B2 (ja) 2018-12-05 2019-11-29 百日咳ブースターワクチン
JP2024126656A Pending JP2024156862A (ja) 2018-12-05 2024-08-02 百日咳ブースターワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024126656A Pending JP2024156862A (ja) 2018-12-05 2024-08-02 百日咳ブースターワクチン

Country Status (6)

Country Link
US (1) US20220054615A1 (enExample)
EP (1) EP3890770A4 (enExample)
JP (2) JP7605739B2 (enExample)
CN (1) CN113395977A (enExample)
TW (1) TWI877126B (enExample)
WO (1) WO2020117618A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021183533A1 (en) * 2020-03-09 2021-09-16 Dynavax Technologies Corporation Active booster immunization against tetanus, diphtheria and pertussis
CN115554395A (zh) * 2022-10-12 2023-01-03 长春百克生物科技股份公司 一种百白破复合佐剂联合疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013229432A1 (en) * 2012-03-08 2014-10-16 Novartis Ag Adjuvanted formulations of booster vaccines
US20150125486A1 (en) 2012-03-08 2015-05-07 Novartis Ag Adjuvanted formulations of pediatric antigens
AU2013301312A1 (en) * 2012-08-06 2015-03-19 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against RSV and B. pertussis
US9526776B2 (en) * 2012-09-06 2016-12-27 Glaxosmithkline Biologicals Sa Combination vaccines with serogroup B meningococcus and D/T/P
WO2016203025A1 (en) * 2015-06-17 2016-12-22 Curevac Ag Vaccine composition

Similar Documents

Publication Publication Date Title
JP4870895B2 (ja) ワクチン組成物
JP2015028032A (ja) ワクチン
RU2008112289A (ru) Множественная вакцинация, включающая менингококки серогруппы с
RU2009149359A (ru) Состав вакцин против менингита
PT1390066E (pt) Composição de vacina
RU2006142156A (ru) Объединенные менингококковые конъюгаты с общим белком-носителем
RU2013136397A (ru) Комбинированная семивалентная вакцина
Mallet et al. A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety
JP2004189751A (ja) 非細胞性（Ａｃｅｌｌｕｌａｒ）百日咳ワクチン及びその調製方法
JP2019142898A (ja) 治療方法
JP2018513218A (ja) 百日咳菌免疫原性ワクチン組成物
Rodgers et al. Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
Giammanco et al. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules
JPWO2020117618A5 (enExample)
Wanlapakorn et al. Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age
Kilpi et al. Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11–12 months of age
RU2014147491A (ru) Антигены и антигенные композиции
Hay What you need to know
TW201008577A (en) Vaccine composition
Božić et al. An overview of current vacccines for the prophylaxis of bacterical infections Pres
Yewale et al. Varicella Vaccines
Petrovsky et al. Progress in the development of an Advax-adjuvanted protein capsular matrix vaccine against typhoid fever
Wong et al. Four is better than nine. A combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia
CN1215337A (zh) 包含一种多糖抗原－载体蛋白共轭物和游离载体蛋白的疫苗
Hornick Immunological control of typhoid fever